Breast Cancer Therapeutics Market
Breast Cancer Therapeutics Market - Global Industry Assessment & Forecast
#
Pages:
149
Base Year:
2023
Jun - 2024
Format:
Report Code:
VMR-2513
Segments Covered
By
Therapy Targeted Therapy, Hormonal Therapy, Chemotherapy, Immunotherapy
-
By
Cancer Type Hormone Receptors, HER2+
-
By
Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
-
By
Region North America, Europe , Asia Pacific , Latin America, Middle-East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 27.34 Billion |
 Revenue 2032:
|
USD 55.18 Billion |
 Revenue CAGR
(2024 - 2032): |
8.12% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Breast Cancer Therapeutics Market Segment Analysis
- Breast Cancer Therapeutics Therapy Outlook (Revenue, USD Million, 2018 - 2030)
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Breast Cancer Therapeutics Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hormone Receptors
- HER2+
- Breast Cancer Therapeutics Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
-
North America Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
-
North America Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- U.S.
- U.S. Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- U.S. Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- U.S. Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- U.S. Breast Cancer Therapeutics Market, by Therapy
- Canada
- Canada Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Canada Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Canada Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Canada Breast Cancer Therapeutics Market, by Therapy
-
Mexico
- Mexico Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Mexico Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Mexico Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Mexico Breast Cancer Therapeutics Market, by Therapy
-
North America Breast Cancer Therapeutics Market, by Therapy
- Europe
-
Europe Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
-
Europe Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
-
Europe Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- U. K.
- U.K. Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- U.K. Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- U.K. Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- U.K. Breast Cancer Therapeutics Market, by Therapy
- France
- France Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- France Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- France Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- France Breast Cancer Therapeutics Market, by Therapy
-
Germany
- Germany Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Germany Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Germany Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Germany Breast Cancer Therapeutics Market, by Therapy
-
Italy
- Italy Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Italy Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Italy Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Italy Breast Cancer Therapeutics Market, by Therapy
-
Spain
- Spain Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Spain Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Spain Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Spain Breast Cancer Therapeutics Market, by Therapy
-
Rest of Europe
- Rest of Europe Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Rest of Europe Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Rest of Europe Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Rest of Europe Breast Cancer Therapeutics Market, by Therapy
-
Europe Breast Cancer Therapeutics Market, by Therapy
- Asia Pacific
-
Asia Pacific Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
-
Asia Pacific Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
-
Asia Pacific Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- China
- China Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- China Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- China Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- China Breast Cancer Therapeutics Market, by Therapy
- Japan
- Japan Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Japan Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Japan Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Japan Breast Cancer Therapeutics Market, by Therapy
-
Germany
- Germany Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Germany Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Germany Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Germany Breast Cancer Therapeutics Market, by Therapy
-
India
- India Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- India Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- India Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- India Breast Cancer Therapeutics Market, by Therapy
-
South Korea
- South Korea Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- South Korea Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- South Korea Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- South Korea Breast Cancer Therapeutics Market, by Therapy
-
South East Asia
- South East Asia Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- South East Asia Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- South East Asia Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- South East Asia Breast Cancer Therapeutics Market, by Therapy
-
Rest of Asia Pacific
- Rest of Asia Pacific Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Rest of Asia Pacific Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Rest of Asia Pacific Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Rest of Asia Pacific Breast Cancer Therapeutics Market, by Therapy
-
Asia Pacific Breast Cancer Therapeutics Market, by Therapy
- Latin America
-
Latin America Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
-
Latin America Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
-
Latin America Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Brazil
- Brazil Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Brazil Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Brazil Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Brazil Breast Cancer Therapeutics Market, by Therapy
- Argentina
- Argentina Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Argentina Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Argentina Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Argentina Breast Cancer Therapeutics Market, by Therapy
-
Rest of Latin America
- Rest of Latin America Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Rest of Latin America Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Rest of Latin America Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Rest of Latin America Breast Cancer Therapeutics Market, by Therapy
-
Latin America Breast Cancer Therapeutics Market, by Therapy
- Middle East & Africa
-
Middle East & Africa Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
-
Middle East & Africa Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
-
Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- GCC Countries
- GCC Countries Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- GCC Countries Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- GCC Countries Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- GCC Countries Breast Cancer Therapeutics Market, by Therapy
- South Africa
- South Africa Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- South Africa Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- South Africa Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- South Africa Breast Cancer Therapeutics Market, by Therapy
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Therapy
- Targeted Therapy
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Cancer Type
- Hormone Receptors
- HER2+
- Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Therapy
-
Middle East & Africa Breast Cancer Therapeutics Market, by Therapy
- North America
Vantage Market
Research | 20-Jun-2024
FAQ
Frequently Asked Question
What is the global demand for Breast Cancer Therapeutics in terms of revenue?
-
The global Breast Cancer Therapeutics valued at USD 27.34 Billion in 2023 and is expected to reach USD 55.18 Billion in 2032 growing at a CAGR of 8.12%.
Which are the prominent players in the market?
-
The prominent players in the market are Pfizer Inc. (U.S.), Novartis AG (Switzerland), Roche Holdings AG (Switzerland), AstraZeneca PLC (UK), Eli Lilly and Company (U.S.), Merck & Co. Inc. (U.S.), Bristol Myers Squibb Company (U.S.), Sanofi (France), Johnson & Johnson Inc. (U.S.), AbbVie Inc. (U.S.), Gilead Sciences Inc. (U.S.), Celgene Corp. (U.S.), Eisai Co. Ltd. (Japan).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.12% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Breast Cancer Therapeutics include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Breast Cancer Therapeutics in 2023.
